Home › Trial NCT03858166
Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer
- Trial IDNCT03858166
- StatusTerminated
- PhasePhase 4
- Study typeInterventional
- SponsorShandong University
- Enrollment68
- Start date2017-12-01
- ConditionsAdjuvant Chemotherapy · Ovarian Neoplasms · Ovarian Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.